Is This Peanut Allergy Treatment Back on the Table?
DBV Technologies is making a comeback after making headway for its peanut allergy treatment in Europe.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 37
COVID-19: This Is the Deadliest County in the Deadliest State in America
Pandemic deaths by state vary widely, and in some parts of the country they are several times the national average. The hardest-hit state by far now is North Dakota.
What This FDA Update Means for Equillium’s COVID-19 Study
Equillium shares jumped on Friday after the company announced a key update from the FDA regarding its late-stage COVID-19 trial.
This Is America’s First County With Over 300,000 COVID-19 Cases
One U.S. county has the largest number of cases among them all counties by far. It is the first county where the number of cases has risen above 300,000.
Moderna’s Financials Aren’t Even the Best Part of Its Report
When Moderna reported its most recent quarterly results before the markets opened on Thursday, the earnings (or loss in this case) were not the most important feature of the report.
COVID-19 Has Shut Down These American Cities at Night
The three largest American cities most recently under curfew orders from their governments are El Paso, Newark and Chicago.
Did Regeneron Just Revive Hopes About Beating COVID-19?
The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in 2020. With cases rising rapidly in the United States and in Europe, more lockdowns…
These Two Major Biotechs Are Bouncing Back With Q3 Results
Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.
More Than Half of US Adults Worry About Medical Bankruptcy, Debt
More than half of American adults are concerned that an unexpected medical bill could lead to crushing debt or bankruptcy.
Does Catabasis Pharma Have a Chance After This DMD Study Flop?
Catabasis Pharmaceuticalswas absolutely devastated on Tuesday after the company announced top-line results from its late-stage study in muscular dystrophy.
Do Merck and Pfizer Earnings Signal a Pullback in Health Care?
Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday, and investors were not thrilled about this quarter for these two pharmaceutical giants.
Major Biotechs Have Short Sellers Looking Both Ways
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The Big COVID-19 Update at BioSig Technologies
BioSig Technologies was absolutely crushed on Monday after the company announced that it would be halting its midstage coronavirus study.
Atea Pharma Announces Potential Pricing for IPO
Clinical-stage biopharmaceutical company Atea Pharma intends to price 11 million shares for and intial public offering valued up to more than $303 million.
Why HCA Healthcare Earnings Aren’t Moving Investors
HCA Healthcare reported earnings per share that were well short of estimates but beat on revenues.